gangliotetraose has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ledeen, RW; Lu, ZH; Meyenhofer, MF; Wang, J; Wang, Y; Wu, G; Xie, X | 1 |
1 other study(ies) available for gangliotetraose and Seizures
| Article | Year |
|---|---|
Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
Topics: Animals; Apoptosis; Brain; Disease Susceptibility; G(M1) Ganglioside; Gangliosides; Hippocampus; Kainic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Acetylgalactosaminyltransferases; Neurons; Neuroprotective Agents; Oligosaccharides; Seizures; Sodium-Calcium Exchanger; Sphingosine; Status Epilepticus; Time Factors | 2005 |